Valuation Freenome, Inc.

Stocks

End-of-day quote Nasdaq 29/09/2026			5-day change	1st Jan Change
15.92 ^USD	-1.67%		-0.44%	+22.18%

09-30	Abbott Launches SimpleScreen Blood Test for Colorectal Cancer	MT
09-20	Freenome, Inc.(NasdaqCM:FRNM) added to S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	144.2	1,754	-	-
Change	-	1,115.96%	-	-
Enterprise Value (EV)	144.2	1,754	1,754	1,754
Change	-	1,115.96%	0%	0%
P/E	-1.57x	-8.28x	-7.31x	-7.19x
PBR	-	-	-	-
PEG	-	0.1x	-0.5x	-4.38x
Capitalization / Revenue	-	17.1x	15.4x	8.43x
EV / Revenue	-	17.1x	15.4x	8.43x
EV / EBITDA	-	1,948x	-9.92x	-10.5x
EV / EBIT	-	-15.1x	-8.16x	-10.2x
EV / FCF	-	-13.1x	-11x	-30x
FCF Yield	-	-7.65%	-9.09%	-3.33%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-8.28	-1.97	-2.233	-2.27
Distribution rate	-	-	-	-
Net sales ¹	-	102.4	113.8	208.1
EBITDA ¹	-	0.9	-176.8	-166.7
EBIT ¹	-	-116.1	-214.8	-171.8
Net income ¹	-219.3	-175.1	-245.7	-257.7
Net Debt	-	-	-	-
Reference price ²	13.03	16.32	16.32	16.32
Nbr of stocks (in thousands)	11,068	107,447	-	-
Announcement Date	30/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FREENOME, INC.	-8.28x	-	-	-	1.75B
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	18.05x	31.37x	12.47x	0.31%	39.23B
Weighted average by Cap.	22.13x	32.04x	13.55x	0.42%